INSIGHTS ON CLINICAL TRIAL DESIGN
-
Clinical Trial Evaluation And Referral Challenging For Physicians
Physicians often encounter information gaps when evaluating clinical trials for patients. A recent survey indicates a fragmented, confusing trial information landscape that is difficult to navigate.
-
Shifting Policies Can Spark Progress In Clinical Trial Diversity
Learn how shifting policies create opportunities for the private sector to prioritize innovation in clinical trials for better healthcare.
-
From Months To Hours: MMC Medical's EDC Revolution
Learn how a specialized CRO reduced study build times by 95%. Discover strategies for template reusability and flexible resource scaling to accelerate early-stage medical device validation.
-
No More Swiss Holes: Filling The Gaps In Clinical Trial Disclosure
This use case shows how sponsors can gain clarity on disclosure requirements when entering a new country.
-
5 Essential Steps To Implementing Decentralized Clinical Trials Globally9/15/2025
Running a global decentralized clinical trial requires a strategy that balances the FDA's focus on technology accessibility with the EMA's emphasis on validation and comprehensive documentation.
-
Local Everywhere: A Global Framework For Participant Engagement, Retention, And Trial Success7/30/2026
Global trials often fail locally when participants face friction and unfamiliarity; however, this practical framework can reduce barriers and keep participants engaged from start to finish.
-
Delivering Specialist Neurology Support4/17/2025
Explore a strategic approach to a Parkinson’s disease trial that leveraged a global infrastructure and multilingual workforce to provide seamless operational and clinical support.
-
The Expanding Role Of GLP-1 Receptor Agonists In CNS Clinical Research7/31/2026
Metabolic drugs show promise for brain disorders. Emerging evidence suggests they reduce addictive behaviors and may help treat neurodegenerative diseases, opening new pathways for addiction and neurological care.
-
Rethinking Patient Representation In Breast Cancer Trials For Better Outcomes5/22/2026
Broad patient representation in breast cancer trials is critical, and inclusive trial design improves data relevance, accelerates enrollment, and supports global approval and access.
CLINICAL TRIAL DESIGN SOLUTIONS
-
Veristat harnesses knowledge, expertise, and scale to provide superior solutions and progressive approaches to mitigate risks and achieve meaningful outcomes for biopharmaceutical and medical technology companies, and their patients.
-
Automate protocol design, database builds, and validation to cut study setup from months to days — enabling faster analytics, earlier insights, and trial simulation.
-
Accelerate clinical trials with expert patient recruitment strategies delivering faster enrollment, lower dropout rates, and better outcomes.
-
When considering clinical trial disclosure solutions, it is important to understand the potential partner’s practical experience and how their solution fits your compliance needs today and in the future.
-
Discover how to seamlessly integrate a broad range of leading industry solutions to create an innovative, patient-centered approach that caters to specific diversity and clinical trial requirements.